Dental Pain Medication Prescriptions in Minas Gerais, Brazil (2011-2021): A Time-Series Analysis.
analgesics
anti-inflammatory agents
dentistry
non-steroidal
prescriptions
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
21 09 2023
21 09 2023
Historique:
received:
22
08
2023
revised:
18
09
2023
accepted:
20
09
2023
medline:
28
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
To describe trends of dentist-prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics, from January 2011 to December 2021, as well as to examine the relationship between these trends and characteristics of public oral health services in Minas Gerais, Brazil. In this time-series analysis, all drugs were classified according to the Anatomical Therapeutic Chemical classification system. Drugs categorized as NSAIDs (M01A), and other analgesics and antipyretics (N02B) were included for analysis. The outcome was the number of Defined Daily Doses (DDDs)/1000 inhabitants/year for NSAIDs and analgesics in each town. Covariates referred to characteristics of public oral health services, such as coverage, estimates of dental procedures, and frequency of toothache. Linear time-series regression models were used to determine the influence of covariates on the outcome. Overall, there were 58,482 prescriptions of NSAIDs recorded in thirty-eight towns, while 47,499 prescriptions of analgesics in forty-three towns. For each year, there was a 0.38 (
Identifiants
pubmed: 37754654
pii: ijerph20186795
doi: 10.3390/ijerph20186795
pmc: PMC10531368
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Front Pharmacol. 2022 Jan 14;12:789872
pubmed: 35115935
Clin Pharmacol Ther. 2021 Jun;109(6):1373-1375
pubmed: 34038591
PLoS One. 2017 May 1;12(5):e0176125
pubmed: 28459825
PLoS One. 2015 Apr 13;10(4):e0122918
pubmed: 25875821
J Oral Pathol Med. 2019 Aug;48(7):647-654
pubmed: 31254315
J Endod. 2017 Jan;43(1):7-15
pubmed: 27939729
J Craniomaxillofac Surg. 2018 Oct;46(10):1731-1736
pubmed: 30077570
Pharmacy (Basel). 2021 Mar 17;9(1):
pubmed: 33802774
J Pharm Pharm Sci. 2013;16(5):821-47
pubmed: 24393558
Int Dent J. 2020 Aug 27;:
pubmed: 32856305
Community Dent Oral Epidemiol. 2017 Aug;45(4):303-309
pubmed: 28251672
Compend Contin Educ Dent. 2020 Oct;41(9):466-473; quiz 474
pubmed: 33001657
Braz Oral Res. 2022 Jan 14;36:e002
pubmed: 35081220
Can J Infect Dis. 2004 Jan;15(1):29-35
pubmed: 18159441
Braz Oral Res. 2020 Dec 18;35:e011
pubmed: 33331405
Braz Oral Res. 2019 Aug 15;33:e076
pubmed: 31432927
Aust Dent J. 2018 Apr 19;:
pubmed: 29676050
Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):16-25
pubmed: 26486230
J Am Dent Assoc. 2019 Oct;150(10):883-889
pubmed: 31561762
Ann Transl Med. 2016 Jan;4(1):9
pubmed: 26855945
PLoS One. 2019 Mar 21;14(3):e0214329
pubmed: 30897156
BMJ. 2018 Nov 14;363:k3532
pubmed: 30429167
Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1353-1363
pubmed: 32419226
Iran Endod J. 2013 Summer;8(3):123-8
pubmed: 23922574
MDM Policy Pract. 2017 Jan 1;2(1):2381468316681006
pubmed: 30288413
J Am Dent Assoc. 2018 Apr;149(4):256-265.e3
pubmed: 29599019
Am J Prev Med. 2021 May;60(5):648-657
pubmed: 33745816
Acta Odontol Scand. 2017 Oct;75(7):496-506
pubmed: 28693407
J Dent. 2022 Oct;125:104254
pubmed: 35977697
Inflammopharmacology. 2009 Dec;17(6):275-342
pubmed: 19949916
Int Dent J. 2021 Dec;71(6):484-490
pubmed: 33648770
J Dent Res. 2020 Jul;99(7):777-786
pubmed: 32286125
Int J Hepatol. 2018 Jan 15;2018:5253623
pubmed: 29568654
Adv Ther. 2020 Jan;37(1):61-82
pubmed: 31705437